Omeros Corp

Find Ratings Reports
OMER : NASDAQ : Health Care
$20.74 up 0.09 | 0.44%
Today's Range: 20.46 - 21.39
Avg. Daily Volume: 996800.0
09/19/17 - 9:43 AM ET

Financial Analysis


OMEROS CORP's gross profit margin for the second quarter of its fiscal year 2017 has significantly increased when compared to the same period a year ago. The company has grown sales and net income significantly, outpacing the average growth rates of competitors within its industry. OMEROS CORP has strong liquidity. Currently, the Quick Ratio is 1.97 which shows the ability to cover short-term cash needs. The company managed to increase its liquidity from the same period a year ago, despite already having strong liquidity to begin with. This would indicate improved cash flow.

During the same period, stockholders' equity ("net worth") has decreased by 11.95% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)17.1510.0
EBITDA ($mil)-11.82-10.86
EBIT ($mil)-11.94-10.93
Net Income ($mil)-14.36-12.61


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)29.6721.24
Total Assets ($mil)60.3546.11
Total Debt ($mil)81.7670.03
Equity ($mil)-54.85-49.0


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin99.77-108.56
EBITDA Margin-68.92-108.55
Operating Margin-69.62-109.25
Sales Turnover0.890.59
Return on Assets-104.45-158.1
Return on Equity0.00.0
Debt Q2 FY17 Q2 FY16
Current Ratio2.142.12
Debt/Capital3.043.33
Interest Expense2.721.86
Interest Coverage-4.38-5.89


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)44.4539.28
Div / share0.00.0
EPS-0.33-0.32
Book value / share-1.23-1.25
Institutional Own % n/a n/a
Avg Daily Volume1050931.0827184.0

Valuation


SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
OMER NM Peers 29.23   OMER NM Peers 25.41

Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.

OMER's P/E is negative making this valuation measure meaningless.

 

Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

OMER's P/CF is negative making the measure meaningless.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
OMER NM Peers 15.70   OMER NA Peers 0.63

Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.

OMER's ratio is negative making this valuation measure meaningless.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

Ratio not available.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
OMER NM Peers 16.15   OMER 23.57 Peers 28.39

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

OMER's P/B is negative making this valuation measure meaningless.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, OMER is expected to trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
OMER 16.89 Peers 9.82   OMER 95.93 Peers 7.05

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

OMER is trading at a significant premium to its industry.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

OMER has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades